Table 2.
Compound | Mode of action | Animal model | Pulmonary hypertension | Preeclampsia | Reference | ||||
---|---|---|---|---|---|---|---|---|---|
Pulmonary artery pressure (PAP)/right ventricular systolic pressure (RVSP) | Right ventricle hypertrophy | Pulmonary artery remodeling | Mean arterial pressure | Proteinuria | Fetal growth | ||||
Hypoxia inducible factor (HIF) pathway | |||||||||
2-methoxyestradiol | HIF-1α inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [239] | |||
2-methoxyestradiol | HIF-1α inhibition | COMT−/− mice | ↓ | ↓ | [254] | ||||
Apigenin | HIF-1α inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [240] | |||
Baicalin | HIF-1α inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [241] | |||
C76 | HIF-2α inhibition | Egln1Tie2Cre mice, monocrotaline (MCT) rats, Sugen/hypoxic rats | ↓ | ↓ | ↓ | [242] | |||
Caffeic acid phenethyl ester | HIF-1α inhibition | MCT rats | ↓ | ↓ | ↓ | [251] | |||
Celastramycin | HIF-1α inhibition | Hypoxic mice, MCT rats, Sugen/hypoxic rats | ↓ | ↓ | ↓ | [243] | |||
Cyclosporin A | HIF-1α inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [244] | |||
Digoxin | HIF-1α inhibition | Hypoxic mice | ↓ | ↓ | ↓ | [245] | |||
Emetine | HIF-1α and HIF-2α inhibition | MCT rats, Sugen/hypoxic rats | ↓ | ↓ | ↓ | [246] | |||
Melatonin | HIF-1α inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [247] | |||
PT2567 | HIF-2α inhibition | Hypoxic rats | ↓ | ↓ | [248] | ||||
Topotecan | HIF-1α inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [249] | |||
YC-1 | HIF-1α inhibition | Hypoxic mice | ↓ | ↓ | ↓ | [250] | |||
R59949 | PHD2 activation | Hypoxic mice | ↓ | ↓ | ↓ | [252] | |||
Anti-CD146 antibody | HIF-1α inhibition | Hypoxic mice | ↓ | ↓ | ↓ | [253] | |||
HIF-1α small hairpin RNA (shRNA) | HIF-1α silencing | Hypoxic rats | ↓ | ↓ | [112] | ||||
Anti-miR-210 oligonucleotide | microRNA-210 (miR-210) inhibition | Sugen/hypoxic mice | ↓ | ↓ | [149] | ||||
mitoROS | |||||||||
Melatonin | mitoROS scavenger | RUPP rats | ↓ | [257] | |||||
MitoQ | Mitochondria-targeted antioxidant | Hypoxic mice | ↔ | ↓ | ↔ | [259] | |||
MitoQ | Mitochondria-targeted antioxidant | RUPP rats | ↓ | ↑ | [263] | ||||
MitoQ | Mitochondria-targeted antioxidant | RUPP mice | ↓ | ↑ | [197] | ||||
MitoQ | Mitochondria-targeted antioxidant | Hypoxic sheep | ↑ | [262] | |||||
MitoQ-nanoparticles (NPs) | Mitochondria-targeted antioxidant | Hypoxic rats | ↑ | [260, 261] | |||||
Mito-Tempo | Mitochondria-targeted antioxidant | RUPP rats | ↓ | ↑ | [263] | ||||
ER stress and the unfolded protein response (UPR) | |||||||||
4-PBA | ER stress inhibition | Hypoxic mice MCT rats | ↓ | ↓ | ↓ | ↓ | [101] | ||
4-PBA | ER stress inhibition | Hypoxic mice | ↓ | ↓ | ↓ | ↓ | [102] | ||
4-PBA | ER stress inhibition | MCT rats | ↓ | ↓ | ↓ | ↓ | [217, 266] | ||
GSK2606414 | PERK inhibition | Sugen/hypoxic rats | ↓ | ↓ | ↓ | ↓ | [267] | ||
H2S | ER stress inhibition | Hypoxic rats | ↓ | ↓ | ↓ | [268] |
Abbreviations: 4-PBA, 4-phenylbutyric acid; C76, compound 76; COMT, catechol-O-methyltransferase; H2S, hydrogen sulfide; MitoQ, Mitochondrial-targeted coenzyme Q; RUPP, reduced uterine perfusion pressure; YC-1, 3-(5’-hydroxymethyl-2’-furyl)-1-benzylindazole.